BPC-157 hasn't been approved by the FDA. But that hasn't stopped this buzzy drug from gaining traction – and attention from MAHA.

BPC-157, a research peptide increasingly referenced in scientific and academic discussions, is the subject of a newly published research The Peptide Blogger, which examines the current state of ...

BPC 157 (Body Protection Compound) and TB 500 (Thymosin Beta-4) are both well-known for their remarkable regenerative properties. Individually, each peptide has been extensively studied and ...

Orlando, FL, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Core Peptides has announced expanded availability of its dual-peptide formulation TB-500 and BPC-157, a complementary pairing recognized in peptide ...